Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

ATNMATNM
14 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in ACTINIUM PHARMACEUTICALS INC

Yes. Qube Research & Technologies holds 57,812 shares of ATNM (Actinium Pharmaceuticals), worth $56,656, as of its Q2 2026 13F filing. It increased the position from 18,048 shares in Q1 2026. Qube Research & Technologies has held ATNM since Q2 2025, across 5 quarterly 13F filings.

Current Value

$56,656

Current Shares

57,812

Total Value Change

-$35,344

Total Shares Change

+38,775

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
57,812
+220.3%
$56,6560.0%$0.98
33
2026-Q1
Decreased
18,048
-4.1%
$17,9630.0%$1.00
0
2025-Q4
Decreased
18,812
-26.9%
$25,5840.0%$1.36
0
2025-Q3
Decreased
25,722
-48.5%
$41,1550.0%$1.60
0
2025-Q2
New
49,932
-
$69,9050.0%$1.40
29
2024-Q4
Exited
0
-100.0%
$00.0%$1.26
0
2024-Q3
New
215,690
-
$405,4970.0%$1.88
33
2024-Q2
Exited
0
-100.0%
$00.0%$7.40
0
2024-Q1
New
3,193
-
$25,0010.0%$7.83
29
2023-Q2
Exited
0
-100.0%
$00.0%$7.42
0
2023-Q1
Increased
58,339
+159.6%
$551,3040.0%$9.45
39
2022-Q4
Decreased
22,472
-3.0%
$239,3270.0%$10.65
0
2022-Q3
Increased
23,155
+21.6%
$171,0000.0%$7.38
27
2022-Q2
New
19,037
-
$92,0000.0%$4.81
30

Other major holders of ATNM: BlackRock Finance, Inc., GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used